SLRX icon

Salarius Pharmaceuticals
SLRX

Overview Fund Activity

46 hedge funds and large institutions have $23.2M invested in Salarius Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 8 closing their positions.

Holders
46
Holders Change
-8
Holders Change %
-14.81%
% of All Funds
1.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
13
Reduced
16
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
1
BlackRock
New York
$2.05M
2
Primecap Management
2
Primecap Management
California
$6.48M
3
RA
3
Royce & Associates
New York
$1.07M
4
SIM
4
Spark Investment Management
New York
$223K
5
CWG
5
C WorldWide Group
Denmark
$1.22M

Top Sellers

1
Jennison Associates
1
Jennison Associates
New York
$0
2
Ameriprise
2
Ameriprise
Minnesota
$1.7M
3
Lazard Asset Management
3
Lazard Asset Management
New York
$0
4
Millennium Management
4
Millennium Management
New York
$422K
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$0
Name Market Value Shares Shares
Change 		Shares
Change %
PA
51
Perceptive Advisors
New York
– – -237 Closed
LTFS
52
Ladenburg Thalmann Financial Services
Florida
$0 100 – –
Simplex Trading
53
Simplex Trading
Illinois
– – – –
Citigroup
54
Citigroup
New York
$0 14 +6 +75%
IA
55
IFP Advisors
Florida
$0 100 +100 New
1 2
3